In a prospective cross-sectional study using point-of-care gastric ultrasonography, fasted patients receiving GLP-1 RA demonstrated a markedly higher prevalence of increased gastric contents compared with matched non-users (56% vs
In addition, in preclinical stages, a combination of GLP-1R agonism with N-methyl-D-aspartate (NMDA) receptor antagonism (GLP-1-MK-801) has been developed [115]
Potential Benefits of Microdosing GLP-1 RAs Reduced Side Effects: Lower doses minimize gastrointestinal discomfort, which can improve patient adherence and overall treatment tolerability
How GLP-1 receptor agonists aid in weight loss
Long-term treatment strategies may be needed to sustain weight loss These considerations underscore the importance of a flexible, individualized approach to weight management when using GLP-1RAs
Clear labeling greatly lessens the need for extensive inquiries and dietary modifications , creating a more enjoyable dining experience for customers and the restaurant employees serving them
.webp)
